HCR 35 Hawaii House · 2026 Regular Session

REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF MANDATORY HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING.

This bill requests the State Auditor of Hawaii to evaluate the social and financial impacts of a new law mandating health insurance coverage for biomarker testing. The assessment will focus on House Bill 1971, which requires insurers to cover medically necessary biomarker testing for diagnosing, treating, and monitoring diseases. The Auditor must submit a report with findings and recommendations to the Legislature before the 2027 session begins. This procedural measure ensures the state reviews the costs and effects of requiring insurance plans to cover this specific medical testing technology.

Bill status passed both 4 of 5 stages cleared

Introduction

Mar 2026

Committee Review

Apr 2026

House Passage

Apr 2026

Senate Passage

Apr 2026

Governor

Introduced Mar 10, 2026 Last action Apr 24, 2026

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 24, 2026

Lower · Passed

Resolution adopted in final form.

lower

Apr 24, 2026

Upper · Passed

Report and Resolution Adopted. Transmitted to House.

upper

Apr 23, 2026

Upper · Passed

Reported from HHS (Stand. Com. Rep. No. 3895) with recommendation of adoption.

upper

Apr 17, 2026

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, UNAMENDED. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

upper

Apr 16, 2026

Committee

Re-Referred to HHS.

upper

Apr 14, 2026

Upper · Passed

The committee(s) on HHS has scheduled a public hearing on 04-17-26 1:00PM; Conference Room 225 & Videoconference.

upper

Apr 10, 2026

Committee

Referred to HHS, WAM.

upper

Apr 10, 2026

Introduced

Received from House (Hse. Com. No. 543).

upper

Apr 9, 2026

Lower · Passed

Adopted with none voting aye with reservations; none voting no (0) and Representative(s) Cochran excused (1).

lower

Apr 9, 2026

Lower · Passed

Reported from FIN (Stand. Com. Rep. No. 1963-26), recommending adoption.

lower

Apr 7, 2026

Lower · Passed

The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 15 Ayes: Representative(s) Todd, Takenouchi, Hartsfield, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lee, M., Miyake, Perruso, Templo, Yamashita, Alcos, Gedeon, Reyes Oda; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Morikawa.

lower

Apr 1, 2026

Lower · Passed

Report adopted; referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and none excused (0).

lower

Apr 1, 2026

Committee

Reported from HLT (Stand. Com. Rep. No. 1598-26), recommending referral to FIN.

lower

Mar 25, 2026

Lower · Passed

The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Hartsfield, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.

lower

Mar 18, 2026

Committee

Referred to HLT, FIN, referral sheet 18

lower

Mar 12, 2026

Introduced

Offered

lower

Mar 10, 2026

Introduced

To be offered.

lower

16 primary · 0 co-sponsors